174 related articles for article (PubMed ID: 35126284)
1. Case Report: Multisystem Autoimmune and Overlapping GAD65-Antibody-Associated Neurological Disorders With Beneficial Effect of Epilepsy Surgery and Rituximab Treatment.
Dimova P; Minkin K
Front Neurol; 2021; 12():756668. PubMed ID: 35126284
[TBL] [Abstract][Full Text] [Related]
2. A case report of anti-GAD65 antibody-positive autoimmune encephalitis in children associated with autoimmune polyendocrine syndrome type-II and literature review.
Sapana T; Li W; Tian F; Yan W; Dou B; Hua S; Zhuo Z
Front Immunol; 2023; 14():1274672. PubMed ID: 38077387
[TBL] [Abstract][Full Text] [Related]
3. Clinical Management of Epilepsy With Glutamic Acid Decarboxylase Antibody Positivity: The Interplay Between Immunotherapy and Anti-epileptic Drugs.
Mäkelä KM; Hietaharju A; Brander A; Peltola J
Front Neurol; 2018; 9():579. PubMed ID: 30057567
[No Abstract] [Full Text] [Related]
4. [Clinical characteristics of four patients with temporal lobe epilepsy associated with elevated anti-GAD antibodies].
Akaishi T; Jin K; Kato K; Itabashi H; Misu T; Tateyama M; Iwasaki M; Aoki M; Nakasato N
Rinsho Shinkeigaku; 2015; 55(11):804-9. PubMed ID: 26369378
[TBL] [Abstract][Full Text] [Related]
5. Glutamic acid decarboxylase 65-positive autoimmune encephalitis presenting with gelastic seizure, responsive to steroid: A case report.
Yang CY; Tsai ST
World J Clin Cases; 2021 Jul; 9(19):5325-5331. PubMed ID: 34307585
[TBL] [Abstract][Full Text] [Related]
6. Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy.
Daif A; Lukas RV; Issa NP; Javed A; VanHaerents S; Reder AT; Tao JX; Warnke P; Rose S; Towle VL; Wu S
Epilepsy Behav; 2018 Mar; 80():331-336. PubMed ID: 29433947
[TBL] [Abstract][Full Text] [Related]
7. Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies.
Malter MP; Frisch C; Zeitler H; Surges R; Urbach H; Helmstaedter C; Elger CE; Bien CG
Seizure; 2015 Aug; 30():57-63. PubMed ID: 26216686
[TBL] [Abstract][Full Text] [Related]
8. Temporal lobe epilepsy with GAD antibodies: neurons killed by T cells not by complement membrane attack complex.
Tröscher AR; Mair KM; Verdú de Juan L; Köck U; Steinmaurer A; Baier H; Becker A; Blümcke I; Finzel M; Geis C; Höftberger R; Mawrin C; von Oertzen TJ; Pitsch J; Surges R; Voges B; Weis S; Winklehner M; Woermann F; Bauer J; Bien CG
Brain; 2023 Apr; 146(4):1436-1452. PubMed ID: 36314080
[TBL] [Abstract][Full Text] [Related]
9. [A case of immune-mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti-glutamic acid decarboxylase antibody].
Kobayakawa Y; Tateishi T; Kawamura N; Doi H; Ohyagi Y; Kira J
Rinsho Shinkeigaku; 2010 Feb; 50(2):92-7. PubMed ID: 20196490
[TBL] [Abstract][Full Text] [Related]
10. Long latency between GAD-antibody detection and development of limbic encephalitis--a case report.
Fauser S; Uttner I; Ariño H; Scherbaum WA; Saiz A; Lewerenz J
BMC Neurol; 2015 Sep; 15():177. PubMed ID: 26420440
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of GAD 65-associated autoimmune encephalitis.
Zhu F; Shan W; Lv R; Li Z; Wang Q
Acta Neurol Scand; 2020 Sep; 142(3):281-293. PubMed ID: 32416610
[TBL] [Abstract][Full Text] [Related]
12. Pre- and long-term postoperative courses of hippocampus-associated memory impairment in epilepsy patients with antibody-associated limbic encephalitis and selective amygdalohippocampectomy.
Hansen N; Ernst L; Rüber T; Widman G; Becker AJ; Elger CE; Helmstaedter C
Epilepsy Behav; 2018 Feb; 79():93-99. PubMed ID: 29253681
[TBL] [Abstract][Full Text] [Related]
13. A unique combination of autoimmune limbic encephalitis, type 1 diabetes, and Stiff person syndrome associated with GAD-65 antibody.
Sharma CM; Pandey RK; Kumawat BL; Khandelwal D; Gandhi P
Ann Indian Acad Neurol; 2016; 19(1):146-9. PubMed ID: 27011652
[TBL] [Abstract][Full Text] [Related]
14. The neurological syndromes associated with glutamic acid decarboxylase antibodies.
Baizabal-Carvallo JF
J Autoimmun; 2019 Jul; 101():35-47. PubMed ID: 31000408
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies.
Falip M; Carreño M; Miró J; Saiz A; Villanueva V; Quílez A; Molins A; Barceló I; Sierra A; Graus F
Eur J Neurol; 2012 Jun; 19(6):827-33. PubMed ID: 22353320
[TBL] [Abstract][Full Text] [Related]
16. Case Report: Autoimmune Encephalitis Associated With Anti-glutamic Acid Decarboxylase Antibodies: A Pediatric Case Series.
Ren C; Ren H; Ren X; Zhang W; Li J; Dai L; Guan H; Fang F
Front Neurol; 2021; 12():641024. PubMed ID: 33912125
[No Abstract] [Full Text] [Related]
17. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis.
Malter MP; Helmstaedter C; Urbach H; Vincent A; Bien CG
Ann Neurol; 2010 Apr; 67(4):470-8. PubMed ID: 20437582
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
19. Seizure semiology and predictors of outcomes in Chinese patients with glutamic acid decarboxylase antibody-associated neurological syndrome.
Lin N; Bai L; Liu Q; Chen J; Ren H; Guan H; Lu Q
BMC Neurol; 2023 Apr; 23(1):149. PubMed ID: 37041500
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
